Elucidating mechanisms of osteogenesis in human adipose-derived stromal cells via microarray analysis

Journal of Craniofacial Surgery

Volumn 21, Issue 4, 2010, Pages 1136-1141

  Lee, Jackie ^a   Gupta, Deepak ^a   Panetta, Nicholas J ^a   Levi, Benjamin ^a   James, Aaron W ^a   Wan, Derrick ^a   Commons, George W ^a   Longaker, Michael T ^a,b  

^a Division of Plastic and Reconstructive Surgery   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CTGF; DKK; Human adipose derived stromal cells; IGF; microarray; osteogenesis; PDGF; TGF B; TNC

Indexed keywords

ALIZARIN; ANTHRAQUINONE DERIVATIVE; CONNECTIVE TISSUE GROWTH FACTOR; CTGF PROTEIN, HUMAN; DKK1 PROTEIN, HUMAN; IGFBP3 PROTEIN, HUMAN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SIGNAL PEPTIDE; SOMATOMEDIN BINDING PROTEIN; TENASCIN; TRANSFORMING GROWTH FACTOR BETA;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; MOUSE; NUDE MOUSE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; UPREGULATION;

ADIPOSE TISSUE; ANALYSIS OF VARIANCE; ANIMALS; ANTHRAQUINONES; CELL DIFFERENTIATION; CONNECTIVE TISSUE GROWTH FACTOR; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOGENESIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 77955087370     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181e488d6     Document Type: Article

References (55)

1. Greenwald AS, Boden SD, Goldberg VM, et al. Bone-Graft Substitutes: Facts, Fictions and Applications. San Francisco, CA: American Academy of Orthopaedic Surgeons, 2008
2. Bostrom R, Mikos A. Tissue engineering of bone. In: Atala A, Mooney DJ, Vacanti JP, et al, eds. Synthetic Biodegradable Polymer Scaffolds, Vol.1. Boston, MA: Birkhauser, 1997:215-234
3. Mulliken JB, Glowacki J. Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg 1980;65:553-560
4. Xu Y, Malladi P, Wagner DR, et al. Adipose-derived mesenchymal cells as a potential cell source for skeletal regeneration. Curr Opin Mol Ther 2005;7:300-305
5. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-4295
6. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7:211-228
7. Xu Y, Malladi P, Chiou M, et al. In vitro expansion of adipose-derived adult stromal cells in hypoxia enhances early chondrogenesis. Tissue Eng 2007;13:2981-2993 (Pubitemid 350233076)
8. Panetta NJ, Gupta DM, Kwan MD, et al. Tissue harvest by means of suction-assisted or third-generation ultrasound-assisted lipoaspiration has no effect on osteogenic potential of human adipose-derived stromal cells. Plast Reconstr Surg 2009;124:65-73
9. Cowan CM, Shi YY, Aalami OO, et al. Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560-567
10. Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004;10:371-380
11. Musina RA, Bekchanova ES, Sukhikh GT. Comparison of mesenchymal stem cells obtained from different human tissues. Bull Exp Biol Med 2005;139:504-509
12. Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-324
13. Egusa H, Iida K, Kobayashi M, et al. Downregulation of extracellular matrixYrelated gene clusters during osteogenic differentiation of human bone marrowY and adipose tissueYderived stromal cells. Tissue Eng 2007;13:2589-2600
14. Wagner W, Wein F, Seckinger A, et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005;33:1402-1416
15. Quarto N, Longaker MT. FGF-2 inhibits osteogenesis in mouse adipose tissueYderived stromal cells and sustains their proliferative and osteogenic potential state. Tissue Eng 2006;12:1405-1418
16. Lendeckel S, Jodicke A, Christophis P, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 2004;32:370-373
17. Bautista CM, Mohan S, Baylink DJ. Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. Metabolism 1990;39:96-100
18. Zhao G, Monier-Faugere MC, Langub MC, et al. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 2000;141:2674-2682
19. Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF1R). Cell 1993;75:59-72
20. Ebeling PR, Jones JD, O'Fallon WM, et al. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women. J Clin Endocrinol Metab 1993;77:1384-1387
21. Gosain AK, Song L, Yu P, et al. Quantitative assessment of cranial defect healing and correlation with the expression of TGF-beta. J Craniofac Surg 2001;12:401-404
22. Longaker MT. Role of TGF-beta signaling in the regulation of programmed cranial suture fusion. J Craniofac Surg 2001;12:389-390
23. Fagenholz PJ, Warren SM, Greenwald JA, et al. Osteoblast gene expression is differentially regulated by TGF-beta isoforms. J Craniofac Surg 2001;12:183-190
24. Gosain AK, Song L, Yu P, et al. Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-beta isoforms. Plast Reconstr Surg 2000;106:360-371 (Pubitemid 30640457)
25. Steinbrech DS, Mehrara BJ, Rowe NM, et al. Gene expression of TGF-beta, TGF-beta receptor, and extracellular matrix proteins during membranous bone healing in rats. Plast Reconstr Surg 2000;105:2028-2038
26. Mehrara BJ, Steinbrech DS, Saadeh PB, et al. Expression of high-affinity receptors for TGF-beta during rat cranial suture fusion. Ann Plast Surg 1999;42:502-508
27. Sagiroglu JS, Mehrara BJ, Chau D, et al. Analysis of TGF-beta production by fusing and nonfusing mouse cranial sutures in vitro. Ann Plast Surg 1999;42:496-501
28. Joyce ME, Roberts AB, Sporn MB, et al. Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur. J Cell Biol 1990;110:2195-2207
29. Marcelli C, Yates AJ, Mundy GR. In vivo effects of human recombinant transforming growth factor beta on bone turnover in normal mice. J Bone Miner Res 1990;5:1087-1096
30. Rosen D, Miller SC, DeLeon E, et al. Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 1994;15:355-359
31. James AW, Xu Y, Lee JK, et al. Differential effects of TGF-beta1 and TGF-beta3 on chondrogenesis in posterofrontal cranial sutureYderived mesenchymal cells in vitro. Plast Reconstr Surg 2009;123:31-43
32. Ripamonti U, Ramoshebi LN, Teare J, et al. The induction of endochondral bone formation by transforming growth factor-beta(3): experimental studies in the non-human primate Papio ursinus. J Cell Mol Med 2008;12:1029-1048
33. Mackie EJ, Tucker RP. Tenascin in bone morphogenesis: expression by osteoblasts and cell type-specific expression of splice variants. J Cell Sci 1992;103(Pt 3):765-771
34. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol 1987;105(6 Pt 1):2569-2579
35. Thesleff I, Kantomaa T, Mackie E, et al. Immunohistochemical localization of the matrix glycoprotein tenascin in the skull of the growing rat. Arch Oral Biol 1988;33:383-390
36. Mackie EJ, Ramsey S. Modulation of osteoblast behaviour by tenascin. J Cell Sci 1996;109(Pt 6):1597-1604
37. Chiquet-Ehrismann R, Hagios C, Schenk S. The complexity in regulating the expression of tenascins. Bioessays 1995;17:873-878
38. Mackie EJ, Abraham LA, Taylor SL, et al. Regulation of tenascin-C expression in bone cells by transforming growth factor-beta. Bone 1998;22:301-307
39. Kawaguchi Y, Ota Y, Kawamoto M, et al. Association study of a polymorphism of the CTGF gene and susceptibility to systemic sclerosis in the Japanese population. Ann Rheum Dis 2008;68:1921-1924
40. Smerdel-Ramoya A, Zanotti S, Stadmeyer L, et al. Skeletal overexpression of connective tissue growth factor impairs bone formation and causes osteopenia. Endocrinology 2008;149:4374-4381
41. Safadi FF, Xu J, Smock SL, et al. Expression of connective tissue growth factor in bone: its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 2003;196:51-62
42. Wang JJ, Ye F, Cheng LJ, et al. Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor. J Zhejiang Univ Sci B 2009;10:355-367
43. Holmen SL, Zylstra CR, Mukherjee A, et al. Essential role of beta-catenin in postnatal bone acquisition. J Biol Chem 2005;280:21162-21168
44. He X, Semenov M, Tamai K, et al. LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004;131:1663-1677
45. Morvan F, Boulukos K, Clement-Lacroix P, et al. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 2006;21:934-945
46. Hadjiargyrou M, Lombardo F, Zhao S, et al. Transcriptional profiling of bone regeneration. Insight into the molecular complexity of wound repair. J Biol Chem 2002;277:30177-30182
47. Xu Y, Malladi P, Zhou D, et al. Molecular and cellular characterization of mouse calvarial osteoblasts derived from neural crest and paraxial mesoderm. Plast Reconstr Surg 2007;120:1783-1795
48. Canalis E, Varghese S, McCarthy TL, et al. Role of platelet derived growth factor in bone cell function. Growth Regul 1992;2:151-155
49. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008;22:1276-1312
50. Sanchez-Fernandez MA, Gallois A, Riedl T, et al. Osteoclasts control osteoblast chemotaxis via PDGF-BB/PDGF receptor beta signaling. PLoS One 2008;3:e3537
51. Akashi K, Traver D, Miyamoto T, et al. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000;404:193-197
52. Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6:230-247
53. Morrison SJ, Lagasse E, Weissman IL. Demonstration that Thy(lo) subsets of mouse bone marrow that express high levels of lineage markers are not significant hematopoietic progenitors. Blood 1994;83:3480-3490
54. Morrison SJ, Wandycz AM, Hemmati HD, et al. Identification of a lineage of multipotent hematopoietic progenitors. Development 1997;124:1929-1939
55. De Ugarte DA, Morizono K, Elbarbary A, et al. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003;174:101-109